Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: pain in her left arm after getting covid vaccine; injection site "achiness"; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 11Aug2021, this case contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient) from a Pfizer Sponsored Program COVAX US Support. A 62-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration on 20Apr2021 (Lot number was not reported) as dose 2, single for covid-19 immunisation. Medical history included allergy to dyes like for MRI, allergy to alcohol, allergy to sulfite containing foods, allergy to narcotics, Sjogren's syndrome, Raynaud's phenomenon, schleroderma antibodies, spider bite or gets stung, and the patient reacted to everything a person with mastocytosis reacts to. The patient was immunocompromised and had multiple allergies, neck and back problems. The patient's concomitant medications were not reported. The patient previously took versed and experienced drug hypersensitivity, epipen for spider bite or stung. Other historical vaccine includes shingle vaccine for immunization in which the patient became sick and influenza vaccine for immunisation and had experienced pyrexia. The patient also previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration on 29Mar2021 (Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient started noticing injection site achiness in May2021 that had not gone away. The patient did not have any allergic reaction to the vaccine, but her left arm/hand would ache sometimes. She stated that she knew that the achiness was not from her neck and back problem because she felt it where she had received her injection. The patient stated that she can use it, but it still ached where she got the shot. The patient was asking if there was a booster dose, and if not, and when there would be, and if it would be the same as the other two doses of the Pfizer BioNTech Covid-19 Vaccine. The patient was asking if the booster would cover Covid-19 variants, especially the Delta Variant. The patient stated that she would be first in line for the booster if and when it was available. The patient was asking if current doses of the Pfizer BioNTech Covid-19 Vaccine were effective against circulating Covid-19 variants, especially the Delta Variant. The patient asked how long protection from the first two doses of the Pfizer BioNTech Covid-19 Vaccine lasts and how long her side effect of injection site pain would last. The patient also asked if someone was exposed to the Delta Variant or any other Covid-19 variant, how long would it take before that person would test positive for Covid- 19. The patient asked if breakthrough infections with variants had occurred after being fully vaccinated with the Pfizer BioNTech Covid-19 Vaccine. The outcome of the events was not recovered.  The lot number for BNT162B2, was not provided and will be requested during follow up.